Waltham, MA, United States of America

Alwin Schuller

This inventor holds 1 USPTO granted patent. Top assignee: Astrazeneca Ab. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alwin Schuller. Retrieved from https://idiyas.com/inventor/alwin-schuller

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Alwin Schuller: Innovator in Cancer Treatment

Introduction

Alwin Schuller is a notable inventor based in Waltham, MA (US). He has made significant contributions to the field of cancer treatment through his innovative work. With a focus on developing effective therapies, Schuller has secured a patent that showcases his dedication to improving patient outcomes.

Latest Patents

Alwin Schuller holds a patent titled "Combination Therapy for Treating Cancer." This patent represents his commitment to advancing medical science and providing new options for cancer patients. He has 1 patent to his name, reflecting his innovative approach to healthcare.

Career Highlights

Schuller is currently employed at AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca allows him to collaborate with other experts in the field and contribute to groundbreaking research and development in cancer therapies.

Collaborations

Throughout his career, Alwin Schuller has worked alongside talented colleagues, including Aatman Doshi and Susan Cantin. These collaborations have fostered an environment of innovation and creativity, leading to advancements in cancer treatment.

Conclusion

Alwin Schuller is a dedicated inventor whose work in cancer treatment exemplifies the impact of innovation in healthcare. His contributions through patents and collaborations continue to inspire progress in the fight against cancer.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…